Titlebook: Inflammatory Bowel Disease; Diagnosis and Therap Russell D. Cohen Book 2017Latest edition Springer International Publishing AG 2017 Biosimi

喊叫

The Biosimilar Revolution: Coming to an IBD Patient Near You?, widely acknowledged to be the most effective agents currently available for the treatment of these conditions. As the initial biologic agents start to come off patent, biosimilar agents have emerged as alternatives to the originator drugs. Given the unique drug development and manufacturing process

Communicate

Nutrition Matters in IBD,utrition screening, assessment, and intervention can minimize the risk of malnutrition. Early detection of nutrient deficiencies, malabsorption, and prompt correction of abnormalities may improve nutritional status and quality of life in IBD. Enteral nutrition is a cost-effective approach to maintai

Frequency

,Size Matters – Special Considerations in the Pediatric IBD Patient,apeutic goals. Since roughly 25% of IBD patients are diagnosed while under the care of pediatricians, it is incumbent on all IBD providers to be familiar with the differences that exist across the age span. These age-dependent contrasts emphasize the conceptualization of IBD as representing a group

半身雕像